Reply

Am J Ophthalmol. 2017 Nov:183:166-167. doi: 10.1016/j.ajo.2017.09.014. Epub 2017 Sep 22.

Authors

Samaneh Davoudi¹, Nazanin Ebrahimiadib², Cagla Yasa¹, Damla D Sevgi¹, Ramak Roohipoor², Evangelia Papavasilieou¹, Jason Comander¹, Lucia Sobrin¹

Affiliations

¹ Boston, Massachusetts.
² Boston, Massachusetts, and Tehran, Iran.

PMID: 28947061
DOI: 10.1016/j.ajo.2017.09.014

No abstract available

Publication types

Letter
Comment

MeSH terms

Autoimmune Diseases* / drug therapy
Humans
Retinal Diseases* / drug therapy
Rituximab

Substances

Rituximab